Literature DB >> 10666772

The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells.

E M Shevach1, J T Chang, B M Segal.   

Abstract

Experimental Allergic Encephalomyelitis (EAE) is a demyelinating disease of the central nervous system which is an animal model for the human autoimmune disease, multiple sclerosis. EAE is mediated by CD4+ T cells and the T cells responsible for disease induction produce Th1 cytokines. IL-12 produced by monocytes and dendritic cells is the most critical factor which influences the development and differentiation of pathogenic autoreactive Th1 cells. Here, we review our recent studies on the critical contributions of IL-12 and the IL-12R beta 2 subunit to the generation of autoreactive effector cells which mediate EAE. In addition, we discuss the potential contribution of IL-18 to the upregulation of the IL-12/IL-12R beta 2 pathway and the contribution of the suppressor cytokines, IL-4 and IL-10, in downregulating this pathway. Collectively, our studies demonstrate that the IL-12/IL-12R beta 2 pathway is a critical intermediary in the process of Th1 differentiation which can be both positively or negatively regulated. This pathway remains an attractive immunotherapeutic target for blockade of function with inhibitory reagents or downregulation by Th2 cytokines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10666772     DOI: 10.1007/bf00812256

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  50 in total

1.  Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells.

Authors:  A Khoruts; S D Miller; M K Jenkins
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

2.  Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

Authors:  D C Wraith; D E Smilek; D J Mitchell; L Steinman; H O McDevitt
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

3.  Developmental commitment to the Th2 lineage by extinction of IL-12 signaling.

Authors:  S J Szabo; N G Jacobson; A S Dighe; U Gubler; K M Murphy
Journal:  Immunity       Date:  1995-06       Impact factor: 31.745

4.  Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis.

Authors:  K Frei; H P Eugster; M Bopst; C S Constantinescu; E Lavi; A Fontana
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

5.  Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.

Authors:  L Büdinger; L Borradori; C Yee; R Eming; S Ferencik; H Grosse-Wilde; H F Merk; K Yancey; M Hertl
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

Review 6.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

7.  An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis.

Authors:  L B Nicholson; J M Greer; R A Sobel; M B Lees; V K Kuchroo
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

8.  Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma.

Authors:  C S Tripp; M K Gately; J Hakimi; P Ling; E R Unanue
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

9.  Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo.

Authors:  M Röcken; J Urban; E M Shevach
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

10.  Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

Authors:  J P Leonard; K E Waldburger; S J Goldman
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  21 in total

1.  A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations.

Authors:  Lara Bossini-Castillo; Jose-Ezequiel Martin; Jasper Broen; Olga Gorlova; Carmen P Simeón; Lorenzo Beretta; Madelon C Vonk; Jose Luis Callejas; Ivan Castellví; Patricia Carreira; Francisco José García-Hernández; Mónica Fernández Castro; Marieke J H Coenen; Gabriela Riemekasten; Torsten Witte; Nicolas Hunzelmann; Alexander Kreuter; Jörg H W Distler; Bobby P Koeleman; Alexandre E Voskuyl; Annemie J Schuerwegh; Øyvind Palm; Roger Hesselstrand; Annika Nordin; Paolo Airó; Claudio Lunardi; Raffaella Scorza; Paul Shiels; Jacob M van Laar; Ariane Herrick; Jane Worthington; Christopher Denton; Filemon K Tan; Frank C Arnett; Sandeep K Agarwal; Shervin Assassi; Carmen Fonseca; Maureen D Mayes; Timothy R D J Radstake; Javier Martin
Journal:  Hum Mol Genet       Date:  2011-11-10       Impact factor: 6.150

2.  CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes.

Authors:  Yaping Yan; Xiaoli Ding; Ke Li; Bogoljub Ciric; Shuai Wu; Hui Xu; Bruno Gran; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Ther       Date:  2012-03-20       Impact factor: 11.454

3.  Interferon beta1a treatment modulates TH1 expression in gammadelta + T cells from relapsing-remitting multiple sclerosis patients.

Authors:  C L Elliott; S Y El-Touny; M L Filipi; K M Healey; M P Leuschen
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

4.  Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitis.

Authors:  Harley Y Tse; Jinzhu Li; Xiaoqing Zhao; Fei Chen; Peggy P Ho; Michael K Shaw
Journal:  Curr Trends Immunol       Date:  2012

5.  Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Neelam Dhiman; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

Review 6.  T helper 17 cells: discovery, function, and physiological trigger.

Authors:  Miriam Beer Torchinsky; J Magarian Blander
Journal:  Cell Mol Life Sci       Date:  2010-01-07       Impact factor: 9.261

7.  Signal transducer and activation of transcription (STAT) 4beta, a shorter isoform of interleukin-12-induced STAT4, is preferentially activated by estrogen.

Authors:  Ebru Karpuzoglu; Rebecca A Phillips; Rujuan Dai; Carmine Graniello; Robert M Gogal; S Ansar Ahmed
Journal:  Endocrinology       Date:  2008-11-06       Impact factor: 4.736

Review 8.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

9.  Generation of a protective T-cell response following coronavirus infection of the central nervous system is not dependent on IL-12/23 signaling.

Authors:  Katherine S Held; William G Glass; Yevgeniya I Orlovsky; Kimberly A Shamberger; Ted D Petley; Patrick J Branigan; Jill M Carton; Heena S Beck; Mark R Cunningham; Jacqueline M Benson; Thomas E Lane
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

10.  Production of interleukin-13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription-6.

Authors:  Iris Bellinghausen; Pia Brand; Ingo Böttcher; Bettina Klostermann; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.